ConductScience.org, home

Paper35636746

Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics.

Balasubramanian R and 5 others. J Acquir Immune Defic Syndr, 2022. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics. Papers, record 35636746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35636746

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Projected Impact of Expanded Long-Acting Injectable PrEP Use Among Men Who Have Sex With Men on Local HIV Epidemics.
PubMed
Journal
J Acquir Immune Defic Syndr
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.45
iCite
Revised in PubMed
2025-07-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Balasubramanian RRuchita
2Kasaie PParastu
3Schnure MMelissa
4Dowdy DWDavid W
5Shah MMaunank
6Fojo ATAnthony Todd

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-HIV AgentsMajor topic
EpidemicsMajor topic
HIV InfectionsMajor topic
Pre-Exposure ProphylaxisMajor topic
Sexual and Gender MinoritiesMajor topic
Homosexuality, Male
Humans
Male
United States

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 AI094189NIAID NIH HHSUnited StatesP30AI094189PubMed and NIHNIH RePORTER
K08 MH118094NIMH NIH HHSUnited StatesK08MH118094PubMed and NIHNIH RePORTER
T32 HL007024NHLBI NIH HHSUnited StatesT32HL007024PubMed and NIHNIH RePORTER
R01 MD018539NIMHD NIH HHSUnited StatesR01MD018539PubMedNIH RePORTER
T32 AI102623NIAID NIH HHSUnited StatesT32AI102623PubMed and NIHNIH RePORTER
K01 AI138853NIAID NIH HHSUnited StatesK01AI138853PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42818812Avoiding the cost of complacency: barriers and solutions to ending the HIV epidemic in Europe.Front Public Health2026https://conductscience.org/library/papers/42818812PubMed
42672112Prospects of HIV elimination among men who have sex with men: A systematic review of modeling studies.PLoS Comput Biol2026https://conductscience.org/library/papers/42672112PubMed
42573428Modelling the 5-Year Impact of Twice-Yearly Injectable Lenacapavir for HIV Pre-Exposure Prophylaxis in the United States.J Int AIDS Soc2026https://conductscience.org/library/papers/42573428PubMed
42178143Equity and Access in HIV Prevention: Addressing Global Disparities in PrEP Use Among Men Who Have Sex With Men Population.Am J Mens Health2026https://conductscience.org/library/papers/42178143PubMed
40755213The great mismatch: unfulfilled promise of biomedical HIV prevention.AIDS2025https://conductscience.org/library/papers/40755213PubMed
39934566Early Implementation of Long-Acting Injectable Cabotegravir for HIV Prevention in a Safety Net Hospital-based Primary Care Center in U.S. South.J Gen Intern Med2026https://conductscience.org/library/papers/39934566PubMed
39484783High Retention and Adherence With Rapid Long-acting Injectable Preexposure Prophylaxis Implementation in an Urban Safety Net Clinic Population.Clin Infect Dis2025https://conductscience.org/library/papers/39484783PubMed
38838028Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.PLoS One2024https://conductscience.org/library/papers/38838028PubMed
38791816LAI-ART Awareness, Willingness, Barriers and Facilitators among Black Sexual Minority Men Living with HIV in the US South.Int J Environ Res Public Health2024https://conductscience.org/library/papers/38791816PubMed
38720248Need for informed providers: exploring LA-PrEP access in focus groups with PrEP-indicated communities in Baltimore, Maryland.BMC Public Health2024https://conductscience.org/library/papers/38720248PubMed
37606684New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact?JAMA2023https://conductscience.org/library/papers/37606684PubMed
36006246Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa.Trop Med Infect Dis2022https://conductscience.org/library/papers/36006246PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35636746

GET https://conductscience.org/api/papers/v1/35636746/authors